Literature DB >> 11204878

Immunoregulation by capsular components of Cryptococcus neoformans.

A Vecchiarelli1.   

Abstract

Cryptococcus neoformans is an encapsulated yeast that is pathogenic for humans. The capsule is a major virulence factor composed mainly of glucuronoxylomannan (GXM) and two minor constituents, galactoxylomannan, and mannoprotein (MP). A hallmark of disseminated cryptococcosis is the presence of high concentrations of GXM in body fluids of infected hosts. GXM provides a critical negative signal for T cell activation and neutrophil migration at the site of the inflammatory process. There is also strong evidence that MP promotes critical events associated with protective responses such as delayed type hypersensitivity and presumably a T helper type 1 response. The contrasting roles of GXM and MP in regulation of the immune response to C. neoformans offer a promising template for a successful approach to intervention, by scavenging GXM to attenuate its negative signals, while preserving the positive effects of MP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11204878     DOI: 10.1080/mmy.38.6.407.417

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  89 in total

Review 1.  Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence.

Authors:  Jim Kronstad; Sanjay Saikia; Erik David Nielson; Matthias Kretschmer; Wonhee Jung; Guanggan Hu; Jennifer M H Geddes; Emma J Griffiths; Jaehyuk Choi; Brigitte Cadieux; Mélissa Caza; Rodgoun Attarian
Journal:  Eukaryot Cell       Date:  2011-12-02

2.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

3.  Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.

Authors:  Marcio L Rodrigues; Leonardo Nimrichter; Débora L Oliveira; Susana Frases; Kildare Miranda; Oscar Zaragoza; Mauricio Alvarez; Antonio Nakouzi; Marta Feldmesser; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2006-11-17

4.  Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

Authors:  David O Beenhouwer; Esther M Yoo; Chun-Wei Lai; Miguel A Rocha; Sherie L Morrison
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

5.  Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level.

Authors:  Aki Yoneda; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2007-12-21

6.  Determinants of virulence in the pathogenic fungi.

Authors:  Arturo Casadevall
Journal:  Fungal Biol Rev       Date:  2007-11       Impact factor: 4.706

7.  New insights on the pathogenesis of invasive Cryptococcus neoformans infection.

Authors:  Helene C Eisenman; Arturo Casadevall; Erin E McClelland
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

8.  Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.

Authors:  J K van de Wetering; F E J Coenjaerts; A B Vaandrager; L M G van Golde; J J Batenburg
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Characterization of phenotypic switching in Cryptococcus neoformans biofilms.

Authors:  Luis R Martinez; David C Ibom; Arturo Casadevall; Bettina C Fries
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

10.  Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan.

Authors:  Javier García-Rivera; Yun C Chang; K J Kwon-Chung; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.